Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EHMT2 | Q96KQ7 | 1/20 | 0.65 |
| ▸ | EHMT1 | Q9H9B1 | 1/20 | 0.65 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.65 |
| ▸ | NPC1 | O15118 | 6/20 | 0.47 |
| ▸ | RAB9A | P51151 | 6/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 6/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.47 |
| ▸ | HPGD | P15428 | 1/20 | 0.47 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.47 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.47 |
| ▸ | FBP1 | P09467 | 1/20 | 0.47 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.46 |
| ▸ | LMNA | P02545 | 2/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | RECQL | P46063 | 1/20 | 0.38 |
| ▸ | GAA | P10253 | 2/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | HTT | P42858 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11825400 | 0.90 | EHMT2 (0.81) | EHMT2EHMT1APOBEC3GNPC1RAB9A | |
| SCHEMBL7203640 | 0.85 | EHMT2 (0.65) | EHMT2EHMT1APOBEC3GNPC1RAB9A | |
| SCHEMBL11824315 | 0.84 | EHMT2 (0.71) | EHMT2EHMT1APOBEC3GNPC1RAB9A | |
| SCHEMBL15044501 | 0.84 | EHMT2 (0.77) | EHMT2EHMT1APOBEC3GNPC1RAB9A | |
| SCHEMBL4439026 | 0.82 | L3MBTL1 (0.67) | EHMT2EHMT1APOBEC3GNPC1RAB9A | |
| Methyl Alcohol SCHEMBL28484914 | 0.81 | EHMT2 (0.90) | EHMT2EHMT1APOBEC3GNPC1RAB9A | |
| SCHEMBL29349787 | 0.81 | EHMT2 (1.00) | EHMT2EHMT1APOBEC3GNPC1RAB9A | |
| SCHEMBL21174 | 0.81 | EHMT2 (1.00) | EHMT2EHMT1APOBEC3GNPC1RAB9A | |
| SCHEMBL27972393 | 0.81 | EHMT2 (1.00) | EHMT2EHMT1APOBEC3GNPC1RAB9A | |
| SCHEMBL30195218 | 0.81 | L3MBTL1 (0.70) | EHMT2EHMT1APOBEC3GNPC1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 209 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117897498-A | RNA preservation and recovery from immobilized cells | 贝克顿迪金森公司 | 2024-04-16 | — | — | CN | claimed |
| CN-115996942-A | Macrophage-targeting peptides, conjugates, compositions and uses thereof | 双亥生命科学株式会社 | 2023-04-21 | — | — | CN | claimed |
| CN-115551638-A | Method and system for physical expansion and imaging of biological samples | 耶鲁大学 | 2022-12-30 | — | — | CN | claimed |
| CN-115087746-A | Intracellular AbSeq | 贝克顿迪金森公司 | 2022-09-20 | — | — | CN | claimed |
| CN-108136254-B | Natural feathers for use in sporting goods | 杜拉博德有限责任公司 | 2021-06-04 | — | — | CN | claimed |
| CN-111629753-A | Immunotoxins, formulations thereof and their use in medicine | 申尼克斯有限公司 | 2020-09-04 | — | — | CN | claimed |
| US-9259488-B2 | Anti-C3d antibody conjugates and methods of detecting complement activation | THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE (US) | 2016-02-16 | — | — | US | claimed |
| US-20150306254-A1 | COMPOSITIONS AND METHODS FOR DETECTING COMPLEMENT ACTIVATION | THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE | 2015-10-29 | — | — | US | claimed |
| WO-2014028865-A1 | COMPOSITIONS AND METHODS FOR DETECTING COMPLEMENT ACTIVATION | THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE (US) | 2014-02-20 | — | — | WO | claimed |
| EP-0683822-B1 | PREPARATION OF PHOTOPROTEIN CONJUGATES AND METHODS OF USE THEREOF | SEALITE SCIENCES INC (US) | 2002-05-02 | — | — | EP | claimed |
| EP-0683822-A4 | PREPARATION OF PHOTOPROTEIN CONJUGATES AND METHODS OF USE THEREOF. | SEALITE SCIENCES INC (US) | 1997-11-05 | — | — | EP | claimed |
| US-5648218-A | CROSSLINKING WITH MALEIMIDE-ACTIVATED BINDER | SEALITE SCIENCES, INC. (US) | 1997-07-15 | — | — | US | claimed |
| EP-0683822-A1 | PREPARATION OF PHOTOPROTEIN CONJUGATES AND METHODS OF USE THEREOF | SEALITE SCIENCES, INC. (US) | 1995-11-29 | — | — | EP | claimed |
| WO-1994018342-A1 | PREPARATION OF PHOTOPROTEIN CONJUGATES AND METHODS OF USE THEREOF | SEALITE SCIENCES, INC. (US) | 1994-08-18 | — | — | WO | claimed |
| US-20260103629-A1 | COMPOSITIONS OF WET ADHESIVES DERIVED FROM VIBRIO CHOLERAE BIOFILM ADHESINS AND METHODS THEREOF | UNIV YALE (US) | 2026-04-16 | — | — | US | disclosed |
| US-20260071003-A1 | COMPOSITIONS AND METHODS FOR DIRECTING APOLIPOPROTEIN L1 TO INDUCE MAMMALIAN CELL DEATH | UNIV GEORGIA (US) | 2026-03-12 | — | — | US | disclosed |
| US-20260028426-A1 | NUCLEAR LOCALIZATION SIGNALS, COMPOSITIONS FORMED THEREFROM, AND METHODS OF USE THEREOF FOR DELIVERY OF CARGO TO THE NUCLEUS | UNIV YALE (US) | 2026-01-29 | — | — | US | disclosed |
| US-5486455-A | LUMINESCENCE | SEALITE SCIENCES, INC. (US) | 1996-01-23 | — | — | US | disclosed |
| EP-0683822-A1 | PREPARATION OF PHOTOPROTEIN CONJUGATES AND METHODS OF USE THEREOF | SEALITE SCIENCES, INC. (US) | 1995-11-29 | — | — | EP | disclosed |
| WO-1994018342-A1 | PREPARATION OF PHOTOPROTEIN CONJUGATES AND METHODS OF USE THEREOF | SEALITE SCIENCES, INC. (US) | 1994-08-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260103629-A1 | COMPOSITIONS OF WET ADHESIVES DERIVED FROM VIBRIO CHOLERAE BIOFILM ADHESINS AND METHODS THEREOF | VCL, VCAM1, BAP1 | EHMT2 904/4885EHMT1 259/4885APOBEC3G 3126/4885 |
| US-20260028426-A1 | NUCLEAR LOCALIZATION SIGNALS, COMPOSITIONS FORMED THEREFROM, AND METHODS OF USE THEREOF FOR DELIVERY OF CARGO TO THE NUCLEUS | PHAX, NXF1, KPNA2 | EHMT2 2129/4885EHMT1 2454/4885APOBEC3G 3366/4885 |
| US-20260071003-A1 | COMPOSITIONS AND METHODS FOR DIRECTING APOLIPOPROTEIN L1 TO INDUCE MAMMALIAN CELL DEATH | APOL1, APOB, LY96 | EHMT2 3817/4885EHMT1 3876/4885APOBEC3G 3027/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.